ADAM9 and thyroid gland carcinoma: Therefore, the main objective of the study was to decipher the roles of RUNDC3A-AS1-miR-182-5p-ADAM9 pathways in thyroid cancer, thereby providing a novel molecular mechanism correlated with the pathology of thyroid cancer and may provide a new direction for the treatment of thyroid cancer metastasis.